Anticoagulation Management for AF Cardioversion — free guideline decision tool
This tool gives the peri-cardioversion anticoagulation strategy for atrial fibrillation by AF duration and hemodynamic stability.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Anticoagulation Management for AF Cardioversion do?
Use to decide pre-cardioversion anticoagulation (or TEE) and the mandatory post-cardioversion course, separating unstable patients who need immediate cardioversion.
How is the result calculated?
Unstable → immediate cardioversion, anticoagulate ASAP. < 48 h → anticoagulate at presentation, low-risk may cardiovert directly. ≥ 48 h/unknown → anticoagulate ≥ 3 weeks or TEE-exclude thrombus. All → ≥ 4 weeks after cardioversion.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Anticoagulation Management for AF Cardioversion now
This tool gives the peri-cardioversion anticoagulation strategy for atrial fibrillation by AF duration and hemodynamic stability.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.